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Background: Human cytogenetics is a field suffering from the argumentation that it ‘is nowadays really outdated
and to be replaced by molecular high throughput approaches’. Thus, it is to be expected that non-cytogeneticists
do mistakes in nomenclature of cytogenetics, which is exposed to repeated reforms, like e.g. recently the now
hardly manageable and readable nomenclature for array-comparative genomic hybridization.
Results: An unexpected nomenclature problem becomes more and more obvious in human cytogenetics – it
seems to become difficult to understand how and when to use the designations “classical cytogenetics” or
“banding cytogenetics”. Here it is highlighted that “classical cytogenetics” stands for studies undertaken by Orcein
or Giemsa staining without (!) previous trypsin-treatment. However, in human (diagnostic) cytogenetics almost
exclusively “banding cytogenetics” is applied.
Conclusion: The terms “classical cytogenetics” and “banding cytogenetics” have to be clearly distinguished and
correctly applied.
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As Editor of Molecular Cytogenetics I felt that it may be
necessary to provide to the community of our field the
following commentary:
Cytogenetics is a field now being ~130 year old [1].
Thus, we should expect it to be a well-accepted and
established area, where everyone working in genetics is
aware of its advantages and unique possibilities (see
Table 1). Well, we all know that this is not the case, un-
fortunately, as our field suffers from the argumentation
that it is outdated and to be replaced by more modern
approaches soon [2–7]. This was even already the case
when I entered this field in 1991, and already before,
when my supervisor Prof. Erich Gebhart (Erlangen,
Germany) published his first articles in 1968 [8], as he
told me. In Germany there is a saying: “People declared
dead live longer”; so this seems to be valid for (molecu-
lar) cytogenetics, too. For example, it is now realized
that the karyotype codes “system inheritance” or the
overall blueprint, which serves as an important tool to
monitor genome instability in cancer and other diseases/
illnesses. Moreover, since chromosomes and genes rep-
resent different levels of genetic information, karyotype
analysis should not be replaced by DNA sequencing, as
the more exciting phase of molecular cytogenetics is yet
to come [7].
It is not at all surprising, that non-specialists for our
field do mistakes in nomenclature of cytogenetics, which
is based on the “international system for human cyto-
genetic nomenclature” (ISCN), or how it was recently
renamed “international system for human cytogenomic
nomenclature” (also ISCN!?) [9]. ISCN was and still is in
parts difficult to understand and matter of discussion
[10–13]. Also some recent reforms of e.g. the array com-
parative genomic hybridization nomenclature led to pro-
found problems with readability, as important hyphens
were abandoned; two examples are given in Table 2.
However, it is really awkward to see that even people
studying chromosomes with devotion and publish in
parts extremely interesting results, seem not to be aware
any more of a simple nomenclature based on the history
of cytogenetics; i.e. when to use the designations “clas-
sical cytogenetics” and “banding cytogenetics”. Already
in 2002 I summarized: “History of human cytogenetics
can be divided into three major time periods: the pre-
Correspondence: Thomas.Liehr@med.uni-jena.de
Institute of Human Genetics, Jena University Hospital, Friedrich Schiller
University, Kollegiengasse 10, D-07743 Jena, Germany
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Liehr Molecular Cytogenetics  (2017) 10:3 
DOI 10.1186/s13039-017-0305-9
banding era (1879–1970), the pure banding era (1970–
1986) and the molecular cytogenetic era (1986–today).
The prebanding era is characterized by the first
visualization the word “chromosome” (from chroma =
color and soma = body) in 1888, the determination of the
correct modal human chromosome number in 1956 and
the detection of the first chromosomal abnormality in
Down syndrome in 1959. The banding era started with
the discovery of the Qbanding method by Dr. Lore Zech
(Upsala) in 1970 [14]. Many more chromosomal abnor-
malities, such as translocations, inversions, deletions and
insertions, could be detected from now on. Currently, the
GTG-banding approach (G-bands by Trypsin using
Giemsa) [15] is still the gold-standard for all cytogenetic
techniques. However, the pure banding era ended in 1986
with the first molecular cytogenetic experiment on human
chromosomes” [1].
For the nomenclature problem raised here it is import-
ant to recall that the pre-banding era was characterized by
the exclusive ability to stain human chromosomes in one
color, e.g. Orcein or Giemsa staining without (!) trypsin-
treatment. In case someone does a study like that, which
is still routinely done in many animal chromosomes [16],
or in mutagenesis studies [8], he performs a “classical
cytogenetic study”. Still, nowadays no-one will do “clas-
sical cytogenetics” in human clinical diagnostic applica-
tions, as here we routinely apply “banding cytogenetics”!
Unfortunately, it is not hard to find published studies
where this difference was not considered (I intentionally
do not refer to them here). Also as editor and referee I get
more and more submissions with the statement ‘we did
classical cytogenetics in this clinical case’. And I have to
say then: ‘no you did not, you did banding cytogenetics;
please correct that point before we can accept your
publication’.
So I herewith want to appeal to all specialists doing
banding cytogenetics and who publish or talk about it,
please denominate correctly the approach you use.
Remember and teach to your students that “classical
cytogenetics” is not equal to “banding cytogenetics”.
Thanks a lot.
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